PapersFlow Research Brief
Liver Diseases and Immunity
Research Guide
What is Liver Diseases and Immunity?
Liver Diseases and Immunity is the study of immune-mediated mechanisms in the diagnosis, management, epidemiology, genetic factors, pathogenesis, immunosuppressive therapy, and liver transplantation for conditions such as autoimmune hepatitis, primary biliary cirrhosis, and primary sclerosing cholangitis.
This field encompasses 38,169 published works on autoimmune liver diseases including autoimmune hepatitis, primary biliary cirrhosis, and primary sclerosing cholangitis. Research covers diagnosis via histological grading systems, management through immunosuppressive therapy, epidemiology, genome-wide association studies, and liver transplantation. Key contributions include standardized histological scoring for chronic hepatitis to assess activity and fibrosis.
Topic Hierarchy
Research Sub-Topics
Autoimmune Hepatitis Pathogenesis
This sub-topic explores the immunological mechanisms, autoantibody profiles, and genetic predispositions underlying autoimmune hepatitis. Researchers study T-cell responses, cytokine dysregulation, and environmental triggers contributing to liver autoimmunity.
Primary Biliary Cholangitis Epidemiology
This sub-topic covers incidence, prevalence, risk factors, and geographic variations in primary biliary cholangitis (PBC). Researchers analyze secular trends, diagnostic delays, and associations with other autoimmune conditions using population-based cohorts.
Primary Sclerosing Cholangitis and IBD
This sub-topic examines the strong association between primary sclerosing cholangitis (PSC) and inflammatory bowel disease, particularly ulcerative colitis. Researchers investigate shared genetic risks, gut-liver axis mechanisms, and differential disease phenotypes.
Immunosuppressive Therapy in Autoimmune Liver Diseases
This sub-topic evaluates efficacy, safety, and steroid-sparing regimens of azathioprine, budesonide, and mycophenolate in autoimmune hepatitis and overlap syndromes. Researchers conduct randomized trials and long-term outcome studies.
Genetic Risk Factors in Autoimmune Liver Diseases
This sub-topic focuses on genome-wide association studies identifying HLA and non-HLA loci predisposing to autoimmune hepatitis, PBC, and PSC. Researchers explore polygenic risk scores and functional validation of susceptibility genes.
Why It Matters
Standardized histological grading enables precise assessment of disease activity and progression in autoimmune and chronic liver diseases, guiding immunosuppressive therapy and transplantation decisions. For instance, "Histological grading and staging of chronic hepatitis" by Ishak et al. (1995) provides a system used in over 4,995 cited studies to score periportal necrosis, intralobular degeneration, portal inflammation, and fibrosis, improving diagnostic consistency across autoimmune hepatitis cases. "International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis" by Álvarez et al. (1999), cited 2,885 times, establishes diagnostic criteria that clinicians apply to differentiate autoimmune hepatitis from viral causes, influencing treatment in hepatology clinics worldwide. These tools directly impact patient outcomes by standardizing management in primary biliary cirrhosis and primary sclerosing cholangitis, where immune dysregulation drives pathogenesis.
Reading Guide
Where to Start
"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis" by Álvarez et al. (1999), as it provides foundational diagnostic criteria essential for understanding immune-mediated liver disease classification before tackling histological details.
Key Papers Explained
"Histological grading and staging of chronic hepatitis" by Ishak et al. (1995) builds on the earlier Knodell Histology Activity Index from "Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis" by Knodell et al. (1981) by refining scores for interface hepatitis and fibrosis, enabling broader application to autoimmune conditions. "An Algorithm for the Grading of Activity in Chronic Hepatitis C" by Bédossa and Poynard (1996) simplifies this into a single activity score, while "Classification of chronic hepatitis: Diagnosis, grading and staging" by Desmet et al. (1994) standardizes terminology across etiologies. "Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions" by Brunt et al. (1999) extends grading to metabolic-immune overlaps.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current research emphasizes genome-wide association studies for genetic risk in autoimmune hepatitis and primary sclerosing cholangitis pathogenesis, alongside optimized immunosuppressive regimens post-transplantation, as indicated by persistent focus on these keywords amid 38,169 works.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Histological grading and staging of chronic hepatitis | 1995 | Journal of Hepatology | 5.0K | ✕ |
| 2 | An Algorithm for the Grading of Activity in Chronic Hepatitis C | 1996 | Hepatology | 4.0K | ✓ |
| 3 | Nonalcoholic Steatohepatitis: A Proposal for Grading and Stagi... | 1999 | The American Journal o... | 3.8K | ✕ |
| 4 | Formulation and application of a numerical scoring system for ... | 1981 | Hepatology | 3.6K | ✓ |
| 5 | Burden of liver diseases in the world | 2018 | Journal of Hepatology | 3.6K | ✕ |
| 6 | Systematic review: the epidemiology and natural history of non... | 2011 | Alimentary Pharmacolog... | 3.1K | ✓ |
| 7 | Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Modera... | 1987 | New England Journal of... | 3.0K | ✕ |
| 8 | The risk of colorectal cancer in ulcerative colitis: a meta-an... | 2001 | Gut | 2.9K | ✓ |
| 9 | International Autoimmune Hepatitis Group Report: review of cri... | 1999 | Journal of Hepatology | 2.9K | ✕ |
| 10 | Classification of chronic hepatitis: Diagnosis, grading and st... | 1994 | Hepatology | 2.6K | ✕ |
Frequently Asked Questions
What are the diagnostic criteria for autoimmune hepatitis?
The International Autoimmune Hepatitis Group established criteria including elevated serum aminotransferases, hypergammaglobulinemia, autoantibodies, and compatible liver histology, excluding viral hepatitis. "International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis" by Álvarez et al. (1999) reviews these features for scoring-based diagnosis. This system aids differentiation from other liver diseases.
How is histological activity graded in chronic hepatitis?
"Histological grading and staging of chronic hepatitis" by Ishak et al. (1995) scores interface hepatitis (0-4), confluent necrosis (0-6), focal lytic necrosis and apoptosis (0-4), portal inflammation (0-4), and fibrosis (0-6), yielding a total score up to 24. This semi-quantitative index assesses necroinflammatory activity independently of etiology. It applies to autoimmune liver diseases for monitoring therapy response.
What scoring system is used for asymptomatic chronic active hepatitis?
"Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis" by Knodell et al. (1981) generates a Histology Activity Index from periportal necrosis (0-10), intralobular necrosis (0-4), portal inflammation (0-4), and fibrosis (0-4). Scores categorize biopsies for clinical trials and management. This index remains foundational for immune-mediated hepatitis evaluation.
How is nonalcoholic steatohepatitis histologically staged?
"Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions" by Brunt et al. (1999) proposes grading for steatosis, lobular inflammation, ballooning, and Mallory bodies, with staging for fibrosis and cirrhosis. This reflects unique features in immune-influenced metabolic liver injury. It standardizes assessment in patients with overlapping autoimmune traits.
What is the role of grading in chronic hepatitis C?
"An Algorithm for the Grading of Activity in Chronic Hepatitis C" by Bédossa and Poynard (1996) uses a simple algorithm for a single activity score based on necroinflammatory lesions. It evaluates periportal/bridge necrosis, lobular activity, and portal inflammation. The score predicts progression in immune-modulated viral hepatitis.
How do classification systems aid chronic hepatitis diagnosis?
"Classification of chronic hepatitis: Diagnosis, grading and staging" by Desmet et al. (1994) standardizes terminology for grading activity and staging fibrosis in chronic hepatitis, including autoimmune forms. It integrates etiology, necroinflammation, and architectural changes. This framework supports consistent reporting across studies.
Open Research Questions
- ? How do genetic factors identified in genome-wide association studies modify immune responses in primary biliary cirrhosis pathogenesis?
- ? What are the long-term outcomes of immunosuppressive therapy in primary sclerosing cholangitis patients post-liver transplantation?
- ? Which immune cell subsets drive histological progression from autoimmune hepatitis to fibrosis?
- ? How does the interplay of epidemiology and viral mimics affect early diagnosis of primary biliary cirrhosis?
- ? What refinements to histological scoring improve prediction of treatment response in autoimmune liver diseases?
Recent Trends
The field maintains steady output with 38,169 works, centering on pathogenesis and management of autoimmune hepatitis, primary biliary cirrhosis, and primary sclerosing cholangitis, without specified 5-year growth data.
Highly cited histological systems like Ishak et al. (1995, 4995 citations) and Bédossa and Poynard (1996, 3972 citations) continue dominating, reflecting reliance on established grading for immune-related diagnostics.
Research Liver Diseases and Immunity with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Liver Diseases and Immunity with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers